This record was last updated July 29, 2025 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.
Summary
This is a pilot, observational, cross-sectional, study on socio-economic burden related to chemotherapy-induced peripheral neurotoxicity (CIPN). Investigators will collect CIPN healthcare related costs on a detailed clinical patient-level. As a sub-study, data obtained in this cross-sectional study, will be compared with administrative larger datasets on patients affected by cancer. The aim is to run a test for potential proxy variables which are available in larger administrative datasets, even if not directly measuring CIPN, to learn more about the impact of CIPN.
Protocol Amendment History
6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2021-07-26; most recent amendment 2025-07-24.
Status change: Not Yet Recruiting → Recruiting2021-08-23